Hospital costs and burden of disease due to yellow fever re-emergence in South America: a Colombian analysis.
- 1Subdirección de enfermedades transmisibles, Ministerio de Salud y Protección Social, Bogotá, Colombia.
- 2Department of Medicine, El Bosque University, Bogotá, Colombia.
- 3Department of Medicine, Juan N. Corpas University Foundation, Bogotá, Colombia.
Abstract
Yellow fever (YF) is an endemic disease in regions of South America that has recently re-emerged in non-endemic areas. To the best of our knowledge, evidence on the hospital costs and burden of YF remains scarce worldwide. This study is the first analysis of the direct hospital costs and burden of disease due to YF in Colombia. A retrospective cross-sectional study was conducted to estimate direct hospital costs and burden of disease due to YF in Colombia during 2025. Direct hospital costs were estimated using a case-based bottom-up costing approach stratified by disease severity according to the Pan American Health Organization Clinical Management and National Guidelines, whereas the burden of disease was assessed using years of life lost (YLLs). During 2025, 125 confirmed YF cases and 45 deaths were identified in Colombia, with a fatality rate of 36%. The total outbreak-related hospital costs were estimated at 1.0 million US dollars, and 1816.98 YLLs were documented, predominantly affecting rural adults aged 27-60 years. The re-emergence of YF in Colombia was associated with substantial hospitalization burden due to the high proportion of moderate and severe cases, resulting in increased demand for high-complexity health care services and high-cost advanced therapies. The concentration of YLLs among working-age adults highlights the disease's social and economic impact.
Related
- Diet-attributable vascular/metabolic disease burden comparisons and public health implications in Western Europe and North America
- Percentile model and usual gait speed reference values in Colombian older adults: a secondary analysis of the Survey on Health, Wellbeing, and Aging in Latin America and the Caribbean (SABE)
- Burden and temporal trends of cardiovascular disease among medical inpatients and age-specific and sex-specific risk of CVD-related hospitalisation at a national referral hospital in Uganda: a retrospective cohort study
- Silent Burden of Mercury: Environmental Exposure and Determinants Among Indigenous Communities in the Colombian Amazon.
- Age- and Site-Specific Ecological Concordance Between Bone Fractures and Alzheimer's Disease and Other Dementias: A Global Burden Analysis with Hospital-Based Contextualization.
BibTeX
@article{ripe2026hospital,
title = {{Hospital costs and burden of disease due to yellow fever re-emergence in South America: a Colombian analysis.}},
author = {Deyna Ripe and Sebastian Alvarez and Mauricio Javier Vera Soto and Nataly Baez and Alan Pirazan and Juan Giraldo},
journal = {IJID regions},
year = {2026},
month = oct,
doi = {10.1016/j.ijregi.2026.101040},
url = {https://europepmc.org/article/MED/42999411},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hospital costs and burden of disease due to yellow fever re-emergence in South America: a Colombian analysis.
AU - Deyna Ripe
AU - Sebastian Alvarez
AU - Mauricio Javier Vera Soto
AU - Nataly Baez
AU - Alan Pirazan
AU - Juan Giraldo
PY - 2026
DA - 2026/10/13
JO - IJID regions
DO - 10.1016/j.ijregi.2026.101040
UR - https://europepmc.org/article/MED/42999411
AB - Yellow fever (YF) is an endemic disease in regions of South America that has recently re-emerged in non-endemic areas. To the best of our knowledge, evidence on the hospital costs and burden of YF remains scarce worldwide. This study is the first analysis of the direct hospital costs and burden of disease due to YF in Colombia. A retrospective cross-sectional study was conducted to estimate direct hospital costs and burden of disease due to YF in Colombia during 2025. Direct hospital costs were estimated using a case-based bottom-up costing approach stratified by disease severity according to the Pan American Health Organization Clinical Management and National Guidelines, whereas the burden of disease was assessed using years of life lost (YLLs). During 2025, 125 confirmed YF cases and 45 deaths were identified in Colombia, with a fatality rate of 36%. The total outbreak-related hospital costs were estimated at 1.0 million US dollars, and 1816.98 YLLs were documented, predominantly affecting rural adults aged 27-60 years. The re-emergence of YF in Colombia was associated with substantial hospitalization burden due to the high proportion of moderate and severe cases, resulting in increased demand for high-complexity health care services and high-cost advanced therapies. The concentration of YLLs among working-age adults highlights the disease's social and economic impact.
SN - 2772-7076
ER -